Skip to main content

Advertisement

Open Peer Review Reports for: Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
27 Dec 2011 Submitted Original manuscript
12 Jan 2012 Reviewed Reviewer Report - Antonio Frassoldati
11 Mar 2012 Reviewed Reviewer Report - Sara Hurvitz
11 Apr 2012 Author responded Author comments - Alessandra Fabi
Resubmission - Version 2
11 Apr 2012 Submitted Manuscript version 2
2 Jul 2012 Reviewed Reviewer Report - Antonio Frassoldati
3 Jul 2012 Reviewed Reviewer Report - Sara Hurvitz
6 Aug 2012 Author responded Author comments - Alessandra Fabi
Resubmission - Version 3
6 Aug 2012 Submitted Manuscript version 3
2 Sep 2012 Reviewed Reviewer Report - Sara Hurvitz
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
22 Sep 2012 Editorially accepted
19 Oct 2012 Article published 10.1186/1471-2407-12-482

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement